Regístrese
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Medical care for refugees: A question of ethics and public health
Información de la revista
Vol. 34. Núm. 2.
Páginas 79-82 (Febrero 2016)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
2963
Vol. 34. Núm. 2.
Páginas 79-82 (Febrero 2016)
Editorial
DOI: 10.1016/j.eimc.2015.12.007
Acceso a texto completo
Medical care for refugees: A question of ethics and public health
La atención médica a los refugiados: una cuestión ética y de salud pública
Visitas
2963
José Antonio Pérez-Molinaa,
Autor para correspondencia
jperezm@salud.madrid.org

Corresponding author.
, Miriam J. Álvarez-Martínezb, Israel Molinac
a CSUR de Medicina Tropical, Servicio de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain
b Servicio de Microbiología, Hospital Clínic Barcelona, ISGLOBAL, Barcelona, Spain
c Servicio de Enfermedades Infecciosas, Hospital Universitario Vall d’Hebron, PROSICS, Barcelona, Spain
Este artículo ha recibido
2963
Visitas
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Tablas (1)
Table 1. Most common infections suitable for screening in asymptomatic immigrants and refugees.
Texto completo

The United Nations High Commission for Refugees (UNHCR) 1951 Refugee Convention (July 28th) on the status of refugees defines a refugee as a person who “owing to well-founded fear of being persecuted for reasons of race, religion, nationality, membership of a particular social group or political opinion, is outside the country of his nationality and is unable or, owing to such fear, is unwilling to avail himself of the protection of that country; or who, not having a nationality and being outside the country of his former habitual residence as a result of such events, is unable or, owing to such fear, is unwilling to return to it”.1

According to the report of the UNHCR published in June 2014, it was estimated that at the end of 2013, a total of 51.2 million people were living outside their home countries because of persecution, armed conflict, violence, and systematic violation of human rights. This is the highest figure recorded since the end of the Second World War. Data from the first six months of 2014 show that, for the first time, Syria has become the main country of origin, followed by Afghanistan, Somalia, South Sudan, Democratic Republic of the Congo, Myanmar, Iraq, and Colombia. The list of countries that accept the most refugees is led by Pakistan, followed by Lebanon, Iran, Turkey, Jordan, Ethiopia, Kenya, Chad, Uganda, and China,2,3 many of which have difficulty attending to the needs of their own populations.

UNHCR data for 2014 show that 866,000 people sought international protection in the 44 most industrialized countries. This is the highest figure recorded in the last 20 years. Of these 44 countries, only 5 (Germany, the United States, Turkey, Sweden, and Italy) received 60% of the requests for asylum. The European Union (28 countries) received 216,000 requests, and the Russian Federation received 168,000 requests (mainly as a result of the conflict in Ukraine). In Turkey, it is estimated that in August 2014, around 1 million people were taken in. Of these, 217,000 were living in refugee camps.4 In the year 2014 alone, it is estimated that 218,000 refugees and migrants crossed the Mediterranean. Of these, at least 3419 died.

During the year 2014 in Spain, a total of 5615 applications for international protection were received, compared with 4285 in 2013 and 2580 in 2012. The main countries of origin were Syria (1510 applicants), Ukraine (895 applicants), and Mali (595 applicants). Nevertheless, only 385 were eventually recognized as refugees in Spain in 2014.2

The crisis now being faced by Europe as a result of the distribution and settlement of refugees led the European Commission to propose a distribution strategy based on four criteria: population, GDP, level of unemployment, and the previous efforts of each country to accept refugees (weighted 40–40–10–10%). Thus, the quota assigned to Spain would be 14,931 refugees, the third highest figure in the EU after Germany (31,443 refugees) and France (24,031).5

Refugees are exposed to serious health risks

Each phase of a refugee's journey (leaving the home country, the journey itself, the arrival, and an eventual return) carries health risks. Starting in their country of origin, refugees suffer the consequences of armed conflict, food shortages, poor medical attention, and the destruction of their communities. All of these factors exert a harmful effect on mental and physical health. The journey does not improve the refugee's condition owing to the many difficulties that have to be faced: lack of suitable health and hygiene, famine, overcrowding, exploitation, accidents, violence, exposure to extreme temperatures, financial ruin, and the distress associated with abandoning one's country of origin.6,7 As an example, of the 137,000 refugees who crossed the Mediterranean between January and June 2015, approximately 1850 are thought to have died or disappeared in the sea, that is, three times more than the 590 who died crossing the sea in all of 2014.8

These factors lead to increases in the frequency of infectious diseases, such as food poisoning, respiratory infections, typhoid fever, cholera, and tuberculosis as well as measles epidemics. The difficulties refugees face are made worse by poor vaccination campaigns (e.g., polio) and sexually transmitted diseases affecting women and girls as a result of abuse and rape. However, one of the major impacts of this situation is on mental health, which takes the form of post-traumatic stress disorder and other conditions, which, in the long term, can exacerbate existing mental disorders, mood disturbances, anxiety disorders, psychosis, and substance abuse.9–11

The potentially most common infections in refugees

The crises during the last 20 years in Iraq, Somalia, Libya, Ivory Coast, Yemen, and, more recently, Syria have revealed a new phenomenon: displaced persons who originate from urban areas and who now make up more than half of all refugees. Furthermore, the sociodemographic and epidemiologic profile of these persons has changed, in that they are now older and from middle-income countries, with a lower prevalence of contagious diseases and more chronic non-infectious diseases.12,13

Immigrant and refugee health status is as much a consequence of exposure, living conditions, and access to health care in the country of origin as it is a consequence of the journey itself.14 Refugees, who by definition have been forced to abandon their country of nationality, are at increased risk of overcrowding, precarious living conditions, and violence. Mental health is a basic element in the health care of these persons.15

Data on the prevalence of infectious diseases among refugees are scarce, although much of the information could probably overlap with that of immigrants from the same region. Therefore, when infectious diseases are suspected among refugees, both cosmopolitan and geographically restricted infections should be borne in mind. Table 1 shows the main infections in terms of public and individual health. The frequency of the different infections depends largely on the region of origin and the living conditions found there. In addition, epidemics are often favored by overcrowding.9,14,16–22 Cases of epidemic louse-borne relapsing fever have recently been reported among Eritrean refugees.23

Table 1.

Most common infections suitable for screening in asymptomatic immigrants and refugees.

Prevalence of infection (%)  Region of origin of the highest prevalence 
HIV infection (0.4–6%)  Sub-Saharan Africa, the Caribbean, Eastern Europe, and Thailand 
Chronic HBV infection (5–16%)  Sub-Saharan Africa, South East Asia, East Asia, Eastern Europe, and the Caribbean 
Chronic HCV infection (1.5–3%)  Sub-Saharan Africa, Egypt, Eastern Europe, and the Indian subcontinent 
Syphilis (1.4–6.1%)  Africa, Central and South America 
Latent tuberculosis (40–71%)  Africa, Eastern Europe, East Asia, the Indian subcontinent, Central and South America 
Strongyloidosis (2–6%)  Sub-Saharan Africa, South East Asia, and Central and South America 
Schistosomiasis (1–15%)  Sub-Saharan Africa 
Intestinal parasitosis (13–58%)  Sub-Saharan Africa, South East Asia, and Central and South America, the Indian subcontinent 
Trypanosoma cruzi infection (15–53%)  Only Latin America (mainly Bolivia) 
Malaria  Malaria can be asymptomatic in up to 4.5% of Sub-Saharan Africans 
Measles, mumps, rubeola, diphtheria, whooping cough, polio, chickenpox, relapsing fever, dysentery  Regions with poor or no vaccination coverage or when vaccination has not been possible. Overcrowding and precarious living conditions favor the spread of these diseases 
Medical care for refugees

Medical care for refugees should take into account both the health status of the migrant and the well being of the host community. Refugees differ from other immigrant groups in that they have specific health care needs. In addition to a greater risk of diseases that are prevalent in their countries of origin (see above), refugees may have been exposed to unhealthy living conditions and subjected to violent acts and traumatic situations. Therefore, clinical care should be based on a multidisciplinary approach that covers infectious diseases, mental health, chronic conditions, and obstetric-gynecologic care.24,25

One of the main strategies for provision of medical care to refugees should be the design and application of screening protocols that can detect the more prevalent health problems early, not only in adults but also in children (infectious diseases, chronic conditions and mental health), and take into consideration the cultural and linguistic peculiarities of the population they are applied to. Such an approach should be complemented by vaccination programs for both children and adults in order to prevent epidemics, especially in vulnerable groups. Ethical considerations aside, these measures require the application of specific resources to ensure that the health of the displaced persons and the host population is not negatively affected.26,27

Screening programs for immigrants and refugees have been questioned from an ethical viewpoint, since they could be considered a limitation to these groups’ rights.28 However, it is important to highlight that a screening program is not a threat in itself, but that ethical considerations could arise with respect to the use made of the results.

The key role of qualified professionals

In recent years, the emergence and re-emergence of infections have proven to be major health problems. More frequent travel, international trade, and migration (unavoidable in some cases and the result of extremely poor living conditions in others), play a major role in the transmission of pathogens. This problem is compounded by increasingly easy international travel and, in the case of undocumented migrants and refugees, the poor conditions of the journey to the host country and the lack of health care during the journey. Examples of recent infections include the H1N1 influenza pandemic in 2009 and infections caused by Middle East Respiratory Syndrome coronavirus (MERS-CoV), West Nile virus, chikungunya virus, and Ebola virus.29 In addition, it is important to remain vigilant with respect to common infections (see above), such as tuberculosis, HIV infection, hepatitis B, hepatitis C, and soil-transmitted helminth infections, whose incidence can increase in developed countries with the arrival of migrants and refugees from areas with poorer health care.17,20,30 We must also be prepared against rare pathogens and infections that are no longer common in our areas but are now being detected among refugees (e.g., cutaneous diphtheria, shigellosis, and louse-borne relapsing fever).9,23,31 Finally, the emergence (or re-emergence) of exotic pathogens is yet another potential risk associated with population movements. Malaria, chikungunya virus infection, dengue fever, and Congo-Crimean hemorrhagic fever are a few examples of diseases that can be transmitted by vectors already present in Spain.29,32–34

In order to address current challenges and those that will undoubtedly appear in the future, we need professionals who are qualified and experienced in the fields of infectious diseases and clinical microbiology. This need has already been demonstrated in infections such as HIV, where the experience of the health care professionals was associated with patient survival.35 Spain has one of the highest percentages of experts in infectious diseases in Europe and is renowned internationally in this field. During the period 2000–2013, Spain occupied the fourth position worldwide in the production of manuscripts in the specialty of infectious diseases and the sixth position for manuscripts in the field of clinical microbiology.36 It is therefore difficult to understand how the field of infectious diseases has not been officially recognized as a medical specialty in its own right. The Spanish Society of Infectious Diseases and Clinical Microbiology has spent 20 years requesting the creation of a specialty in infectious diseases,37 yet no system has been created to ensure that training in infectious diseases and the physicians working in this area benefit from legal recognition. In most neighboring countries, the specialty of infectious diseases is fully recognized.38 Royal Decree 639/2014 (dated 25th July)39 does nothing to improve this situation, since it excludes infectious diseases as a new specialty and relegates microbiology to a branch of laboratory work with a training program that is insufficient to cover present and future needs.

It is paradoxical that a group of professionals who have never failed to step up to the challenges presented by infectious diseases (AIDS epidemic, emergence of multiresistant pathogens, rational use of antimicrobial drugs, infections in transplant recipients, and severe emergencies such as Ebola virus disease) receive almost no recognition from the health authorities. Moreover, the education and training possibilities proposed in the Royal Decree are patently insufficient according to the recommendations of the European Union in Directive 2005/36/EC and the European Union of Medical Specialists in the section of infectious diseases.40,41 Given the scarce incentives to train in these areas, the transfer of knowledge between generations of clinical microbiologists and infectious disease specialists is under threat. This problem will clearly have a negative impact on future crises and on the daily care of patients.

Conclusions

The extent of the refugee crisis goes far beyond the human dignity and safety of displaced persons. Its reach is much wider through the spread of epidemics, political instability, and the potential emergence of violent conflicts. With respect to health in general and infectious diseases in particular, refugees are a particularly vulnerable group, as a result of the poor conditions in their country of origin and during their journey. Health care protocols must be implemented for the diagnosis and prevention of infectious diseases, while taking into account mental health, chronic conditions, and pediatric care.

References
[1]
ACNUR.
Convención sobre el Estatuto de los Refugiados.
(1951),
[2]
CEAR.
Comisión Española de ayuda al Refugiado. Informe 2015: Las personas refugiadas en España y Europa.
(9 June 2015),
[3]
UNHCR – The UN Refugee Agency, unhcr.org. http://www.unhcr.org/cgi-bin/texis/vtx/home [accessed 29.11.15].
[4]
UNHCR Global Appeal 2015 Update – Northern, Western, Central and Southern Europe subregional overview [Internet]. unhcr.org. http://www.unhcr.org/5461e60d155.html [accessed 29.11.15].
[5]
European Commission – Press release – Refugee Crisis – Q&A on Emergency Relocation.
(2015),
[6]
International Organization for Migration.
International Migration, Health and Human Rights.
(2013),
[7]
L.O. Gostin, A.E. Roberts.
Forced migration.
JAMA, 314 (2015), pp. 2125-2132
[8]
ACNUR. La crisis del Mediterráneo 2015 a seis meses: las cifras de refugiados e inmigrantes más altas [Internet]. acnur.es. Available at: http://www.acnur.es/noticias/notas-de-prensa/2148-2015-07-01-15-24-30 [accessed 29.11.15].
[9]
I. Lederer, K. Taus, F. Allerberger, S. Fenkart, A. Spina, B. Springer, et al.
Shigellosis in refugees, Austria, July to November 2015.
(2015),
[10]
J.-B. Wasserfallen, A. Hyjazi, M. Cavassini.
Comparison of HIV-infected patients’ characteristics, healthcare resources use and cost between native and migrant patients.
Int J Public Health, 54 (2009), pp. 5-10
[11]
T. Nicolai, O. Fuchs, E. Mutius von.
Caring for the wave of refugees in Munich.
N Engl J Med, 373 (2015), pp. 1593-1595
[12]
A. Guterres, P. Spiegel.
The state of the world's refugees: adapting health responses to urban environments.
JAMA, 308 (2012), pp. 673-674
[13]
S. Doocy, E. Lyles, T. Roberton, L. Akhu-Zaheya, A. Oweis, G. Burnham.
Prevalence and care-seeking for chronic diseases among Syrian refugees in Jordan.
BMC Public Health, 15 (2015), pp. 1097
[14]
L. Seybolt, E.D. Barnett, W. Stauffer.
US medical screening for immigrants and refugees: clinical issues.
Immigrant medicine,
[15]
M. Bogic, A. Njoku, S. Priebe.
Long-term mental health of war-refugees: a systematic literature review.
BMC Int Health Hum Rights, 15 (2015), pp. 29
[16]
V.J. Redditt, P. Janakiram, D. Graziano, M. Rashid.
Health status of newly arrived refugees in Toronto, Ont Part 1: Infectious diseases.
Can Fam Physician, 61 (2015), pp. e303-e309
[17]
E.D. Barnett, L.H. Weld, A.E. McCarthy, H. So, P.F. Walker, W. Stauffer, et al.
Spectrum of illness in international migrants seen at GeoSentinel clinics in 1997–2009, Part 1: US-bound migrants evaluated by comprehensive protocol-based health assessment.
Clin Infect Dis, 56 (2013), pp. 913-924
[18]
K. Pottie, C. Greenaway, J. Feightner, V. Welch, H. Swinkels, M. Rashid, et al.
Evidence-based clinical guidelines for immigrants and refugees.
CMAJ, 183 (2011), pp. e824-e925
[19]
B. Monge-Maillo, R. Lopez-Velez, F.F. Norman, F. Ferrere-González, A. Martinez-Perez, J.-A. Perez-Molina.
Screening of imported infectious diseases among asymptomatic sub-Saharan African and Latin American immigrants: a public health challenge.
Am J Trop Med Hyg, 92 (2015), pp. 848-856
[20]
C. Bocanegra, F. Salvador, E. Sulleiro, A. Sánchez-Montalvá, A. Pahissa, I. Molina.
Screening for imported diseases in an immigrant population: experience from a teaching hospital in Barcelona, Spain.
Am J Trop Med Hyg, 91 (2014), pp. 1277-1281
[21]
J. Gascon, C. Bern, M.A.-J. Pinazo.
Chagas disease in Spain, the United States and other non-endemic countries.
[22]
N. Coppola, L. Alessio, L. Gualdieri, M. Pisaturo, C. Sagnelli, N. Caprio, et al.
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013.
Euro Surveill, 20 (2015), pp. 30009-30013
[23]
K. Wilting, Y. Stienstra, B. Sinha, M. Braks, D. Cornish, H. Grundmann.
Louse-borne relapsing fever (Borrelia recurrentis) in asylum seekers from Eritrea, the Netherlands, July 2015.
Euro Surveill, 20 (2015), pp. 21196-21203
[24]
W.M. Stauffer, D. Kamat, P.F. Walker.
Screening of international immigrants, refugees, and adoptees.
Prim Care, 29 (2002), pp. 879-905
[25]
J. Fortún, P. Martín-Dávila, E. Navas, R. Lopez-Velez, V. Pintado, J. Cobo, et al.
Changes in the epidemiology of tuberculosis: the influence of international migration flows.
Enferm Infecc Microbiol Clin, 29 (2011), pp. 654-659
[26]
A. Rivadeneyra-Sicilia, S. Minué Lorenzo, C. Artundo Purroy, S. Márquez Calderón.
Lecciones desde fuera. Otros países en ésta y otras crisis anteriores. Informe SESPAS 2014.
GACETA Sanit, 28 (2014), pp. 12-17
[27]
J.A. Perez-Molina, F. Pulido.
Comité de expertos del Grupo para el Estudio del Sida (GESIDA) de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC).
Enferm Infecc Microbiol Clin, 33 (2015), pp. 437-445
[28]
University of Minnesota.
Committee on the Protection of the Rights of all Migrant Workers and Members of Their Families, General Comment No. 1, U.N. Doc. CMW/C/GC/1.
(2011),
[29]
Emerging and vector-borne diseases. ecdc.europa.eu. http://ecdc.europa.eu/en/publications/surveillance_reports/evd/Pages/evd.aspx [accessed 15.07.15].
[30]
B. Monge-Maillo, B.C. Jiménez, J.A. Perez-Molina, F.F. Norman, M. Navarro, A. Pérez-Ayala, et al.
Imported Infectious diseases in mobile populations, Spain.
Emerg Infect Dis, 15 (2009), pp. 1745-1752
[31]
European Centre for Disease Prevention and Control.
Cutaneous diphtheria among recently arrived refugees and asylum seekers in the EU, 30 July 2015.
ECDC, (2015),
[32]
J.C. Semenza, H. Zeller.
Integrated surveillance for prevention and control of emerging vector-borne diseases in Europe.
Euro Surveill, 19 (2014),
[33]
S. Santos-Sanz, M.J. Sierra-Moros, L. Oliva-Iñiguez, A. Sanchez-Gómez, B. Suarez-Rodriguez, F. Simón-Soria, et al.
Possible introduction and autochthonous transmission of dengue virus in Spain.
Rev Esp Salud Publica, 88 (2014), pp. 555-567
[34]
P. Santa-Olalla Peralta, M.C. Vazquez-Torres, E. Latorre-Fandos, P. Mairal-Claver, P. Cortina-Solano, A. Puy-Azón, et al.
First autochthonous malaria case due to Plasmodium vivax since eradication, Spain, October 2010.
Euro Surveill, 15 (2010), pp. 19684
[35]
E. Wood, R.S. Hogg, B. Yip, P.R. Harrigan, M.V. O'Shaughnessy, J.S.G. Montaner.
Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?.
[36]
J.M. Ramos, G. González-Alcaide, F. Gutiérrez.
Análisis bibliométrico de la producción científica española en Enfermedades Infecciosas y en Microbiología.
Enferm Infecc Microbiol Clin, (2015),
[37]
A.M. Muñoz Sanz, J. Pachón.
Manifiesto de Guadalupe: por el reconocimiento de la especialidad de enfermedades infecciosas en España.
Enferm Infecc Microbiol Clin, 26 (2008), pp. 65-66
[38]
R.C. Read, G. Cornaglia, G. Kahlmeter, et al.
Professional challenges and opportunities in clinical microbiology and infectious diseases in Europe.
Lancet Infect Dis, 11 (2011), pp. 408-415
[39]
Boletín Oficial De Estado.
Real Decreto 639/2014, de 25 de julio, por el que se regula la troncalidad, la reespecialización troncal y las áreas de capacitación específica, se establecen las normas aplicables a las pruebas anuales de acceso a plazas de formación y otros aspectos del sistema de formación sanitaria especializada en Ciencias de la Salud y se crean y modifican determinados títulos de especialista.
(2014),
[40]
Directiva 2005/36/CE del Parlamento Europeo y del Consejo de 7 de septiembre de 2005 relativa al reconocimiento de cualificaciones profesionales. Diario Oficial de la Unión Europea.
(2005),
[41]
European Union of Medical Specialist U.E.M.S..
European Training Charter for Medical Specialists, UEMS 2008. European Board of Infectious Diseases.
(2008),
Copyright © 2016. Elsevier España, S.L.U. y Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.